In previous reports, administration of recombinant angiostatin after cancer cell injection in vivo blocked the formation of metastases by γ-IR[39], and neutralization of TGF-β with its specific antibody inhibited γ-IR-induced metastasis[56]. Here, TGFB1 is linked to cancer.